Hostname: page-component-7b7567c8c-8p88z Total loading time: 0 Render date: 2026-11-19T13:53:37.933Z Has data issue: false hasContentIssue false

Examining the Relationship between Cognitive Function and Sleep Disturbance in Pregnancy and Postpartum

Published online by Cambridge University Press:  31 July 2026

Y. Schmitt
Affiliation:
Psychiatry, Icahn School of Medicine at Mount Sinai, New York, United States
L. Ospina
Affiliation:
Psychiatry, Icahn School of Medicine at Mount Sinai, New York, United States
M. MccLure
Affiliation:
Psychiatry, Icahn School of Medicine at Mount Sinai, New York, United States
M. M. Perez-Rodriguez*
Affiliation:
Psychiatry, Icahn School of Medicine at Mount Sinai, New York, United States
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.
Introduction

The impact of sleep disturbances on cognitive function is well-established in the general population. However, during the psychiatric high-risk periods of pregnancy and postpartum, characterized by substantial sleep disturbances, the impact of sleep on cognition is understudied. Some studies have found that the connection between sleep disturbance and cognitive function may be strongest among individuals experiencing depressive symptoms.

Objectives

We administered a comprehensive cognitive battery in pregnant and postpartum individuals and examined its relationship with sleep disturbance in the third trimester of pregnancy and at three months postpartum.

Methods

Participants completed the Cambridge Neuropsychological Test Automated Battery (CANTAB) in the 3rd trimester (N=274) and at 3 months postpartum (N=203). Tasks assessed executive functioning (One Touch Stockings of Cambridge, Cambridge Gambling Task), memory (Paired Associates Learning, Spatial Working Memory, Delayed Matching to Sample, Pattern Recognition Memory), and attention (Rapid Visual Information Processing). A subset also completed the PHQ-9, a screening measure which assesses sleep difficulty, and the Edinburgh Postnatal Depression Scale (EPDS). Sleep disturbance was defined as a score >0 on PHQ-9 item 3. A cross-sectional analysis was performed at each time point correlating the PHQ-9 item with the 7 individual cognitive task z-scores and composite domain scores using Spearman’s rank correlation. Additionally, the correlation between change in sleep items and z-scores within participants at each time point was examined using Spearman’s rank correlation. Finally, we examined the prevalence of mild cognitive impairment, defined as a z-score ≤−1, across both timepoints and its association PHQ-9 item 3. Analyses were performed at three levels: (1) unadjusted, (2) stratified by EPDS total (<10 vs ≥10), and (3) adjusted for EPDS score using rank-based regression.

Results

During pregnancy, 51.7% had a sleep disturbance on PHQ-9 item 3 (N=149). At 3 months postpartum 30.2% had a sleep disturbance on PHQ-9 item 3 (N=129). Greater increases in sleep disturbance were associated with greater decreases in quality of decision making on the Cambridge Gambling Task between pregnancy and postpartum (Estimate = -0.45, P = 0.01; N = 62), after adjusting for EDPS depression scores. In unadjusted and EPDS stratified analysis, there were no significant cross-sectional or longitudinal associations between PHQ-9 sleep scores and cognition.

Conclusions

We found an association between increased sleep disturbance between pre-and post-partum and quality of decision making when controlling for depression. Further research is needed to explore potential mediating factors and to use more fine-grained measures of sleep quality and duration.

Disclosure of Interest

Y. Schmitt: None Declared, L. Ospina: None Declared, M. MccLure: None Declared, M. M. Perez-Rodriguez Grant / Research support from: Principal Investigator of Grant to Mount Sinai from Neurocrine Biosciences (unrelated to this presentation), Consultant of: Consultant with Neurocrine Biosciences and Mitsubishi Tanabe Pharma Corporation (unrelated to this presentation).

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.